ZA895936B - Pharmaceutical compositions comprising selected lactobacillus strains - Google Patents

Pharmaceutical compositions comprising selected lactobacillus strains

Info

Publication number
ZA895936B
ZA895936B ZA895936A ZA895936A ZA895936B ZA 895936 B ZA895936 B ZA 895936B ZA 895936 A ZA895936 A ZA 895936A ZA 895936 A ZA895936 A ZA 895936A ZA 895936 B ZA895936 B ZA 895936B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
lactobacillus strains
selected lactobacillus
gynecolocy
urologic
Prior art date
Application number
ZA895936A
Other languages
English (en)
Inventor
Silvana Tosi
Tosi Silvana
Giancarla Dondi
Dondi Giancarla
Vittorio Bottazzi
Bottazzi Vittorio
Franco Dellacglio
Dellacglio Franco
Lorenzo Morelli
Morelli Lorenzo
Original Assignee
Tosi A Dr Farmaceut Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosi A Dr Farmaceut Srl filed Critical Tosi A Dr Farmaceut Srl
Publication of ZA895936B publication Critical patent/ZA895936B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
ZA895936A 1988-08-05 1989-08-03 Pharmaceutical compositions comprising selected lactobacillus strains ZA895936B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8821663A IT1227154B (it) 1988-08-05 1988-08-05 Composizioni farmaceutiche per uso ginecologico a base di lattobacilli

Publications (1)

Publication Number Publication Date
ZA895936B true ZA895936B (en) 1990-05-30

Family

ID=11185025

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895936A ZA895936B (en) 1988-08-05 1989-08-03 Pharmaceutical compositions comprising selected lactobacillus strains

Country Status (7)

Country Link
US (1) US5176911A (xx)
EP (1) EP0353581B1 (xx)
JP (1) JPH02174675A (xx)
AT (1) ATE113650T1 (xx)
DE (1) DE68919146D1 (xx)
IT (1) IT1227154B (xx)
ZA (1) ZA895936B (xx)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672494A1 (fr) * 1991-02-13 1992-08-14 Madinier Isabelle Ferments prophylactiques favorisant la prevention de la carie dentaire.
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
FI92498C (fi) * 1992-06-10 1994-11-25 Valio Meijerien Uusi mikro-organismikanta, sitä sisältävät bakteerivalmisteet ja näiden käyttö hiivojen ja homeiden torjuntaan
US5269959A (en) * 1992-09-16 1993-12-14 Gary Schreibman Liquid deep cleaning detergent composition
ZA942302B (en) * 1993-12-03 1995-09-29 Lafor Lab Ltd Viracidal bactericidal and spermicidal vaginal suppository
JPH11504048A (ja) * 1996-02-14 1999-04-06 ザ、プロクター、エンド、ギャンブル、カンパニー 泌尿生殖器および腸用の組成物
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
EP0872231B1 (en) * 1997-04-14 2002-09-04 Dr. A. Tosi Farmaceutici S.R.L. Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
WO1998047374A1 (en) * 1997-04-18 1998-10-29 Ganeden Biotech, Inc. Topical use of probiotic bacillus spores to prevent or control microbial infections
US7507402B1 (en) 1997-04-18 2009-03-24 Ganeden Biotech, Inc. Topical use of probiotic Bacillus spores to prevent or control microbial infections
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
SE519648C2 (sv) * 1998-03-06 2003-03-25 Essum Ab Ny stam av Lactobacillus plantarum
US6811786B1 (en) 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
DE69802260T2 (de) 1998-04-30 2002-07-04 Vesely Renata Maria Cavaliere Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
EP1719518A1 (en) 1998-08-07 2006-11-08 Ganeden Biotech, Inc. Compositions comprising bacillus coagulans for increasing the solubility and bioavailability of nutritional minerals
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
EP1212093B1 (en) 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
US6767537B2 (en) * 2000-05-26 2004-07-27 Phil Arnold Nicolay Composition and method for the treatment of sinusitis
WO2001097821A1 (en) * 2000-06-19 2001-12-27 Mucoprotec Pty Ltd Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor.
DE60136366D1 (de) * 2000-08-11 2008-12-11 David R Whitlock Ammoniak-oxidierende bakterien enthaltende zusammensetzungen zur steigerung der stickoxidproduktion, stickoxid-vorläufer und verfahren zu deren verwendung
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
EE04580B1 (et) * 2001-06-29 2006-02-15 Tartu �likool Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
EP1472021A4 (en) * 2002-01-11 2008-04-16 David R Whitlock AMMONIAX OXIDIZING BACTERIA CONTAINING COMPOSITIONS AND USER METHOD THEREFOR
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
WO2006045347A1 (en) * 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
KR100720025B1 (ko) 2005-09-27 2007-05-21 (주)바이오토피아 프로바이오틱 유산균 및 이를 포함하는 조성물
US20070286813A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
KR100720024B1 (ko) 2006-12-20 2007-05-18 (주)바이오토피아 프로바이오틱 비피도박테리움 보움 ｒ5 균주 및 이를포함하는 조성물
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
JP5520223B2 (ja) 2007-08-29 2014-06-11 ガネーデン バイオテック インコーポレイテッド 焼き製品
EP2217083B1 (en) * 2007-10-16 2018-09-05 Ganeden Biotech, Inc. Beverage compositions
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2158916A1 (en) * 2008-08-27 2010-03-03 Ellen Aktiebolag Administration unit comprising lactic acid bacteria
BR122017003315B1 (pt) 2008-10-16 2018-01-16 Ganeden Biotech, Inc. Composições alimentícias compreendendo grãos e esporos isolados de bacillus coagulans, bem como seu método de preparação
US20100260695A1 (en) * 2009-04-09 2010-10-14 Mary Kay Inc. Combination of plant extracts to improve skin tone
EP2424550B1 (en) 2009-04-29 2017-06-07 Ganeden Biotech, Inc. Bacterial cell membrane formulation
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
JP4942831B2 (ja) 2010-03-19 2012-05-30 株式会社キティー 抗アレルギー用組成物
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
EP2709456A1 (en) 2011-05-20 2014-03-26 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Paenibacillus alvei strain ts-15 and its use in controlling pathogenic organisms
CA3107450A1 (en) 2012-03-29 2013-10-03 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
EP2656862A1 (en) 2012-04-24 2013-10-30 The Procter & Gamble Company Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate
WO2014106541A1 (en) * 2013-01-04 2014-07-10 Ellen Ab Dermal composition for use in the external genital area in females
JP6464142B2 (ja) 2013-03-14 2019-02-06 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
CA3207619A1 (en) 2014-04-15 2015-10-22 Aobiome Llc Ammonia-oxidizing nitrosomonas eutropha strain d23
MX2018002533A (es) 2015-09-29 2018-06-27 Kimberly Clark Co Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora.
PL241510B1 (pl) 2015-11-06 2022-10-17 Probios Spolka Z Ograniczona Odpowiedzialnoscia Nowy szczep Lactobacillus plantarum AMT14 i kompozycja zawierająca szczep Lactobacillus plantarum AMT14
US10166262B2 (en) 2017-04-20 2019-01-01 Ewelina Sosnowska-Turek Strain of bacteria and composition comprising the same
WO2022006205A1 (en) * 2020-06-30 2022-01-06 Vireo Systems, Inc. Compositions and methods for treatment of vaginal infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6836M (xx) * 1967-11-29 1969-03-31
DK127268A (xx) * 1970-01-12 1900-01-01
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection

Also Published As

Publication number Publication date
EP0353581B1 (en) 1994-11-02
DE68919146D1 (de) 1994-12-08
EP0353581A2 (en) 1990-02-07
IT1227154B (it) 1991-03-19
IT8821663A0 (it) 1988-08-05
EP0353581A3 (en) 1990-08-01
US5176911A (en) 1993-01-05
ATE113650T1 (de) 1994-11-15
JPH02174675A (ja) 1990-07-06

Similar Documents

Publication Publication Date Title
EP0353581A3 (en) Pharmaceutical compositions comprising selected lactobacillus strains
HK184896A (en) Pharmaceutical composition comprising loratadine ibuprofen and pseudoephedrine
MX9603560A (es) Composiciones de prostaglandinas estables en almacenamiento.
AU2206188A (en) Azithromycin and derivatives as antiprotozoal agents
AU633714B2 (en) New uses of l-deprenyl and compositions for same
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
IE873125L (en) Benzimidazole derivatives
IL103213A (en) Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics
PT86539A (en) Pharmaceutical composition for the prophylaxis and therapy of gastric ulcer
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
AU553269B2 (en) 2,3-diaryl-5-halo thiophenes
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
DE3885468D1 (de) Mittel zur verringerung des lipidperoxidgehaltes.
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
GR3005231T3 (xx)
AU8838291A (en) The use of carbazones as novel active ingredients in medicaments
IT8721657A0 (it) Eteri e tioeteri ad attivita'terapeutica, loro preparazione e composizioni che li contengono.
LV5677A3 (lv) Bakteriju lactobacillus casei var. alactosus celms - L(+)-pienskabes producents izmantojams lopbaribas konservesanai
IL60123A (en) Pharmaceutical composition for the treatment of bactericidal infections of the urinary and genital tracts comprising lactobacillus acidophilus or doederlein's bacillus
Finston Evolution of the Genus Stomion (Coleoptera: Tenebrionidae) in the Galapagos Islands.
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments
IT9021846A1 (it) Involucro pretettivo, particolarmente studiato per l'impiego in ambito ospedaliero.
Szabo Cato's letters and the doctrine of civic humanism
IT1244360B (it) Preparato di zinco idrossido per la terapia nell'uomo dell'ulcera gastrica e duodenale
ATE62593T1 (de) Physiologisch wirksame und naehrende zusammensetzung.